preloader

M/S. THEMIS PHARMACEUTICALS

F.NO. 8 (7)/2005/DP/NPPA-Div.II

GOVERNMENT OF INDIA
MINISTRY OF CHEMICALS AND FERTILIZERS
NATIONAL PHARMACEUTICAL PRICING AUTHORITY

NEW DELHI, DATED THE 30/3/2005

ORDER

In exercise of the powers, conferred by sub-paragraph (1)/(2)/(4) of paragraph 8 and paragraph 11 of the Drugs (Price Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority hereby fixes/revises the prices as specified in column (7) of the Table hereto annexed as the retail price/revised retail price, exclusive of local tax if any, in relation to each of the formulations specified in the corresponding entry in column (2) of the said Table with pack size specified in the corresponding entries in column (3) thereof;

TABLE

Sl. No. Name of the Formulation Pack Size Existing Retail Price (Rs.) Retail Price without Excise Duty Excise Duty (Rs.) Revised Retail Price with Excise Duty (Rs.)
1 E.mycin Tablets
Each tab contains
Erythromycin (as Estolate) 100mg
10’s Strip/Blister 8.80 0.96 9.76
2 E.mycin Tablets
Each tab contains
Erythromycin (as Estolate) 250mg
10’s Strip/Blister 20.80 2.26 23.06
3 E.mycin Dry Syrup
Each 5 ml contains
Erythromycin (as Estolate) 100mg
30ml Bottle with M. Cup 10.54 1.14 11.68
4 E.mycin Dry Syrup/Suspension
Each 5 ml contains
Erythromycin (as Estolate) 100mg
60ml Bottle with M. Cup 16.94 1.84 18.78
  1. This order shall be applicable if the manufacturer of the formulation specified in column (2) of the Table above has complied with the requirements, if any, of

(a)         the Drugs and Cosmetics Act, 1940 (23 of 1940) and the rules made thereunder; and

(b)         the Industries (Development and Regulation) Act, 1951 (65 of 1951) as amended from time to time.

3.(a)     The prices fixed/revised are the maximum retail prices (inclusive of excise duty and exclusive of local taxes, if any) for the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.

(b)        For different packing material used or any special feature claimed, companies are required to approach NPPA for approval/fixation of specific prices.

  1. The ceiling price fixed for Erythromycin Estolate based formulation will not be applicable in this case.
  2. These prices/revised prices shall be made effective within 15 days of receipt of this order as required under sub para 14(1) of DPCO, 1995. The necessary price-list should also be issued as required under sub-paragraph (3) of paragraph 14 of the Drugs (Prices Control) Order, 1995.

(A. K. PAL)
Dy. Director

PN/80/2005/F
M/s Themis Pharmaceuticals
38, Suren Road, Andher (E),
Mumbai-400093

 

Last Page Updated: 07-06-2019